Follow the PharmaCyte Biotech, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). The latest transaction was reported on 7 January 2026 (Acquisition). Among the most active insiders: Silverman Joshua. The full history is openly available.
7
Insider Decl.
n/a
Thresholds
€33,358
2 ops.
Buy Volume
n/a
n/a
Sell Volume
46Σ signal
Buys €33,358n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
PharmaCyte Biotech, Inc. is a biopharmaceutical company focused on developing treatments for cancer and other serious diseases. It utilizes a stem cell technology to create innovative therapies.